A meta‐analysis verified that US alone had lower sensitivity rates for early‐stage HCC (RR 0.81; 95% CI 0.71–0.93) and any‐stage HCC (RR 0.88; 95% CI 0.83–0.93) than US plus AFP [221]. The gene discussed is AFP; the disease is hepatocellular carcinoma.